The initial public offering (IPO) of pharmaceutical company Rubicon Research is set to close for public bidding today. The ₹ 1,377.5-crore IPO was subscribed 18 times so far on October 13 (Day 3).

The maiden public issue of the company received bids for nearly 29.68 crore shares as against the offer size of 1.64 crore shares, according to data on NSE at 1 pm.

Retail and Non Institutional Investors (NII) have fully booked their reserved portions, subscribing them 18.17 times and 43.86 times so far. Qualified Institutional Buyers (QIB) have booked 5.12 times of the portion reserved for them.

Ahead of listing, the unlisted shares of Rubicon Research were trading at a premium of 20% in the grey market, according to data on Investorgain.

Rubicon Research has mobilised ₹ 619 crore from a

See Full Page